• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 234-248 of 1,261 results

2014 Exhibit: EX2014 Excerpt of Redacted Patent Owner’s Response, Mylan Phar...

Document IPR2024-00009, No. 2014 Exhibit - EX2014 Excerpt of Redacted Patent Owner’s Response, Mylan Pharms Inc v Novo Nordisk AS, IPR2023 00724, Pap30 Jan 17, 2023 (P.T.A.B. Jan. 26, 2024...

cite Cite Document
Analyze

1074 Exhibit: WO 0037098

Document IPR2024-00009, No. 1074 Exhibit - WO 0037098 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1073 Exhibit: US Patent No 6,458,924

Document IPR2024-00009, No. 1073 Exhibit - US Patent No 6,458,924 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1097 Exhibit: Mylan Pharma Inc, v Novo Nordisk IPR2023 00724, Paper 10, Oct 4, ...

Document IPR2024-00009, No. 1097 Exhibit - Mylan Pharma Inc, v Novo Nordisk IPR2023 00724, Paper 10, Oct 4, 2023 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1045 Exhibit: Shargel, APPLIED BIOPHARMACEUTICS PHARMACOKINETICS 5th...

Document IPR2024-00009, No. 1045 Exhibit - Shargel, APPLIED BIOPHARMACEUTICS PHARMACOKINETICS 5th ed 2005 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1019 Exhibit: Bell, Hamster Preproglucagon 302 NATURE 716 1983

Document IPR2024-00009, No. 1019 Exhibit - Bell, Hamster Preproglucagon 302 NATURE 716 1983 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1004 Exhibit: CV of John Bantle, MD

Document IPR2024-00009, No. 1004 Exhibit - CV of John Bantle, MD (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1095 Exhibit: Declaration of Dr Maureen M Donovan

Document IPR2024-00009, No. 1095 Exhibit - Declaration of Dr Maureen M Donovan (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1048 Exhibit: FDA Guidance for Industry, Analysis, and Regulatory Applns Apr 200...

Document IPR2024-00009, No. 1048 Exhibit - FDA Guidance for Industry, Analysis, and Regulatory Applns Apr 2003 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1087 Exhibit: Prosecution history excerpts for US Patent No 9,764,003

Document IPR2024-00009, No. 1087 Exhibit - Prosecution history excerpts for US Patent No 9,764,003 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1043 Exhibit: US Patent App Pub 20040102486

Document IPR2024-00009, No. 1043 Exhibit - US Patent App Pub 20040102486 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1072 Exhibit: US Patent No 5,164,366

Document IPR2024-00009, No. 1072 Exhibit - US Patent No 5,164,366 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1082 Exhibit: Scheduling Order, No 22 294 CFC, D Del June 30, 2022, ECF No 22

Document IPR2024-00009, No. 1082 Exhibit - Scheduling Order, No 22 294 CFC, D Del June 30, 2022, ECF No 22 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1054 Exhibit: Landersdorfer, Mechanism Based,73 BRIT J CLINICAL PHARMACOL...

Document IPR2024-00009, No. 1054 Exhibit - Landersdorfer, Mechanism Based,73 BRIT J CLINICAL PHARMACOLOGY 391 2011 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1020 Exhibit: Bydureon prescribing information Jan 2012

Document IPR2024-00009, No. 1020 Exhibit - Bydureon prescribing information Jan 2012 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 16 17 18 19 20 ... >>